| Literature DB >> 35880869 |
Danieli Conte1,2, Dany Mesa1,2, Thomas Jové3, Caetana Paes Zamparette4, Thaís Cristine Marques Sincero5,4, Jussara Kasuko Palmeiro2,5,4, Libera Maria Dalla-Costa1,2.
Abstract
Mobile genetic elements contribute to the emergence and spread of multidrug-resistant bacteria by enabling the horizontal transfer of acquired antibiotic resistance among different bacterial species and genera. This study characterizes the genetic backbone of blaGES in Aeromonas spp. and Klebsiella spp. isolated from untreated hospital effluents. Plasmids ranging in size from 9 to 244 kb, sequenced using Illumina and Nanopore platforms, revealed representatives of plasmid incompatibility groups IncP6, IncQ1, IncL/M1, IncFII, and IncFII-FIA. Different GES enzymes (GES-1, GES-7, and GES-16) were located in novel class 1 integrons in Aeromonas spp. and GES-5 in previously reported class 1 integrons in Klebsiella spp. Furthermore, in Klebsiella quasipneumoniae, blaGES-5 was found in tandem as a coding sequence that disrupted the 3' conserved segment (CS). In Klebsiella grimontii, blaGES-5 was observed in two different plasmids, and one of them carried multiple IncF replicons. Three Aeromonas caviae isolates presented blaGES-1, one Aeromonas veronii isolate presented blaGES-7, and another A. veronii isolate presented blaGES-16. Multilocus sequence typing (MLST) analysis revealed novel sequence types for Aeromonas and Klebsiella species. The current findings highlight the large genetic diversity of these species, emphasizing their great adaptability to the environment. The results also indicate a public health risk because these antimicrobial-resistant genes have the potential to reach wastewater treatment plants and larger water bodies. Considering that they are major interfaces between humans and the environment, they could spread throughout the community to clinical settings. IMPORTANCE In the "One Health" approach, which encompasses human, animal, and environmental health, emerging issues of antimicrobial resistance are associated with hospital effluents that contain clinically relevant antibiotic-resistant bacteria along with a wide range of antibiotic concentrations, and lack regulatory status for mandatory prior and effective treatment. blaGES genes have been reported in aquatic environments despite the low detection of these genes among clinical isolates within the studied hospitals. Carbapenemase enzymes, which are relatively unusual globally, such as GES type inserted into new integrons on plasmids, are worrisome. Notably, K. grimontii, a newly identified species, carried two plasmids with blaGES-5, and K. quasipneumoniae carried two copies of blaGES-5 at the same plasmid. These kinds of plasmids are primarily responsible for multidrug resistance among bacteria in both clinical and natural environments, and they harbor resistant genes against antibiotics of key importance in clinical therapy, possibly leading to a public health problem of large proportion.Entities:
Keywords: ESBL; MLST; carbapenemase; integrons; multireplicons
Mesh:
Substances:
Year: 2022 PMID: 35880869 PMCID: PMC9430818 DOI: 10.1128/spectrum.02469-21
Source DB: PubMed Journal: Microbiol Spectr ISSN: 2165-0497
Susceptibility profile of Aeromonas spp. and Klebsiella spp. from hospital effluents
| Strain, GES type | MIC (mg/L) of: | ESBL | Carbapenemases | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AMI | CAZ | CAZ-AVI | CFDC | CTX | CPM | CIP | CST | ERT | GEN | IMI | IMI-REL | MER | MER-VAB | POL | TIG | Class A | Class B | ||
| 4 | 8 | 0.5 | 2 | 4 | 1 | 0.25 | 0.25 | 0.03 | 0.5 | 0.12 | 0.12 | 0.03 | 0.12 | 1 | 0.5 | + | − | − | |
| 32 | 8 | ≤0.015 | 1 | 4 | 0.25 | 0.25 | 0.12 | 0.03 | 1 | 0.12 | 0.12 | 0.03 | ≤0.015 | 1 | 1 | + | − | − | |
| 8 | 16 | 0.25 | 2 | 4 | 64 | 0.5 | 0.5 | 0.03 | 1 | 0.12 | 0.12 | 0.5 | 2 | 1 | 0.5 | + | − | − | |
| 32 | >64 | ≤0.015 | 1 | >128 | 32 | 0.25 | 0.5 | >64 | 32 | >128 | 0.25 | 32 | 0.25 | 1 | 1 | + | + | + | |
| >32 | >64 | ≤0.015 | 0.06 | 64 | 16 | 4 | 0.5 | >64 | 64 | >128 | >8 | 64 | >32 | 2 | 1 | + | − | + | |
| >32 | >64 | 1 | 0.5 | >128 | 64 | 4 | 0.25 | 64 | >128 | 32 | 2/4 | 32 | 2 | 2 | 8 | + | + | − | |
| 8 | >64 | 1 | 2 | 32 | 4 | 1 | 0.25 | 64 | 16 | 16 | 0.25 | 32 | 2 | 1 | 0.5 | + | + | − | |
| 32 | >16 | ND | ND | 4 | <4 | 0.5 | 0.25 | <0.25 | 2 | <0.5 | ND | <0.5 | ND | 1 | <1 | + | − | − | |
| 2 | 0.5 | 0.25 | 0.015 | 0.12 | 0.06 | ≤0.06 | 0.25 | 0.03 | 0.5 | 0.25 | 0.12 | 0.06 | 0.03 | 1 | ≤0.06 | + | − | − | |
| 2 | >32 | 2 | 0.12 | 4 | 0.25 | ≤0.06 | 0.12 | 0.015 | 2 | 0.25 | 0.25 | 0.03 | 0.03 | 1 | ≤0.06 | + | − | − | |
| 1 | 4 | 0.5 | 0.03 | 0.5 | 0.06 | ≤0.06 | 0.25 | 0.12 | 0.25 | 0.5 | 0.25 | 0.25 | 0.03 | 1 | ≤0.06 | + | − | − | |
| 1 | 0.5 | 0.12 | 0.12 | ≤0.06 | ≤0.03 | ≤0.06 | 0.12 | ≤0.015 | 0.25 | ≤0.12 | 0.12 | ≤0.015 | ≤0.015 | 2 | ≤0.06 | − | − | − | |
| 2 | 0.25 | 0.12 | 0.12 | ≤0.06 | 0.06 | ≤0.06 | 0.12 | ≤0.015 | 0.25 | ≤0.12 | 0.12 | ≤0.015 | ≤0.015 | 1 | ≤0.06 | − | − | − | |
AMI, amikacin; CAZ, ceftazidime; CAZ-AVI, ceftazidime-avibactam; CFDC, cefiderocol; CTX, cefotaxime; CPM, cefepime; CIP, ciprofloxacin; CST, colistin; ERT, ertapenem; GEN, gentamicin; IMI, imipenem; IMI-REL, imipenem-relebactam; MER, meropenem; MER-VAB, meropenem-vaborbactam; POL, polymyxin B; TIG, tigecycline; ND, not determined.
The MIC of ceftazidime was measured with a fixed avibactam concentration of 4 mg/L.
The MIC of imipenem was measured with a fixed relebactam concentration of 4 mg/L.
The MICs of meropenem were measured with a fixed vaborbactam concentration of 8 mg/L except for K. grimontii KOX60, which was measured with a fixed vaborbactam concentration of 4 mg/L.
(+), positive phenotypic test; (−), negative phenotypic test.
Sequence type, genome characteristics, and blaGES-encoding plasmids of Aeromonas spp. and Klebsiella spp. from hospital effluents
| Strain | Genome | Length (bp) | GC% | MLST | Inc group | Integron | Resistance genes | GenBank accession no. |
|---|---|---|---|---|---|---|---|---|
| Chromosome | 4,371,624 | 61.6 | 884 |
| ||||
| p1 | 110,559 | 58.9 | Nontypeable | In2062 |
| |||
| Chromosome | 5,123,400 | 60.6 | 885 |
| ||||
| p1 | 244,072 | 57.8 | Nontypeable | In2029 |
| |||
| Chromosome | 4,386,545 | 61.6 | 884 |
| ||||
| p1 | 111,631 | 58.9 | Nontypeable | In2062 |
| |||
| Chromosome | 5,060,940 | 58.3 | 886 |
| ||||
| p1 | 80,584 | 56.6 | P6 | In2059 |
| |||
| Chromosome | 4,905,987 | 58.5 | 257 |
| ||||
| p2 | 9,413 | 54.1 | Q1 | In2061 |
| |||
| Chromosome | 5,696,094 | 57.5 | 5527 |
| ||||
| p1 | 170,976 | 53.5 | M1 | In200 |
| |||
| Chromosome | 6,070,417 | 55.6 | 350 |
| ||||
| p2 | 136,576 | 54.9 | FII-FIA | In174 |
| |||
| p3 | 128,898 | 54.3 | FII | In174 |
|
czcD, cobalt-zinc-cadmium resistance gene; mer, mercury operon.
FIG 1Schematic representation of regions enclosing class 1 integrons detected among the bacterial population analyzed in the present survey. (A) A. caviae (Aero19) In2062; (B) A. caviae (Aero21) In2029; (C) A. caviae (Aero52) In2062; (D) A. veronii (Aero22) In2059. The 3′ CS in In2059 is truncated by IS26. (E) A. veronii (Aero28) In2061. The yellow ray means the attC is disrupted, and therefore, the gene cassette cannot be mobilized anymore. The 3′ CS is truncated by IS6100. (F) K. quasipneumoniae (KPN47) In200. A star means premature intI1 STOP codon and frameshift in orf5. (G) K. grimontii (p2KOX60), In174; (H) K. grimontii (p3KOX60), In174. Blue, conserved 5′ CS and 3′ CS; green, gene cassettes; purple, insertion sequences; //, 10-kb gap with different genes.
FIG 2Map of the plasmids carrying blaGES-5 from KPN47 and KOX60 recovery at CHC/UFPR effluents. (A) The representative genes of the K. quasipneumoniae from the CP066860 plasmid are shown in colored boxes. (B) The representative genes of the K. grimontii from the CP067435 plasmid and CP067436 plasmid are shown in colored boxes.